logo-loader
viewMotif Bio PLC

Motif Bio chief talks up potential US listing

Motif Bio (LON:MTFB) said a listing on the US tech market NASDAQ is very much an option as it brought on board an American investment bank.

MTS Health Partners will advise on its future financing options within the US market, investors were told.

Chief executive Graham Lumsden told Proactive: “One of the differences between the London markets and the US is that there are a large number of specialist pharma-biotech investors in the US.”

What MTS is helping the firm to do, he said, is understand “how we identify the right investors in the US, what our story needs to be, and how we communicate with these people.”

Quick facts: Motif Bio PLC

Price: 0.265 GBX

AIM:MTFB
Market: AIM
Market Cap: £1.29 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Motif Bio PLC named herein, including the promotion by the Company of Motif Bio PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Motif Bio announces US FDA approval deadline for its antibiotic drug

Motif Bio (LON:MTFB, NASDAQ: MTFB) CEO Graham Lumsden tells Proactive Investors the US FDA has begun the process of assessing whether the company’s next-generation antibiotic should be allowed to go on sale in the US. Motif's drug iclaprim has been granted a priority review by the...

on 08/15/2018

RNS

Second Price Monitoring Extn

4 days, 14 hours ago

Price Monitoring Extension

4 days, 14 hours ago

Holding(s) in Company

1 week, 3 days ago

Second Price Monitoring Extn

1 week, 4 days ago

Price Monitoring Extension

1 week, 4 days ago

Second Price Monitoring Extn

1 week, 4 days ago

Price Monitoring Extension

1 week, 4 days ago

Holding(s) in Company

1 week, 6 days ago

2 min read